Limits...
Correlation Between Clinical-Pathologic Factors and Long-Term Follow-Up in Young Breast Cancer Patients.

Zhao Y, Dong X, Li R, Song J, Zhang D - Transl Oncol (2015)

Bottom Line: Group 3 in risk factor grouping has the poorer prognosis than the other two groups.Patient age and axillary lymph nodes post-surgery are the independent and significant predictors of distant disease-free survival, local recurrence-free survival, and overall survival.The absence of PR relates to poor prognosis.

View Article: PubMed Central - PubMed

Affiliation: Department of Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.

No MeSH data available.


Related in: MedlinePlus

Patient age with outcome. (A) Patient age in relation to LRFS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 50 months; patients 31 to 35 years old, 87 months. (B) Patient age in relation to DDFS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 65 months; patients 31 to 35 years old, > 99 months. (C) Patient age in relation to OS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 89 months; patients 31 to 35 years old, 92 months.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4562982&req=5

f0010: Patient age with outcome. (A) Patient age in relation to LRFS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 50 months; patients 31 to 35 years old, 87 months. (B) Patient age in relation to DDFS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 65 months; patients 31 to 35 years old, > 99 months. (C) Patient age in relation to OS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 89 months; patients 31 to 35 years old, 92 months.

Mentions: In our study, patient age (≤ 35) was an independent predictor of patient’s prognosis both in univariate and multivariate analyses (Figure 2, A–C, and Tables 1 and 5). Patients younger than 30 have poorer prognosis compared to patients of age between 31 and 35.


Correlation Between Clinical-Pathologic Factors and Long-Term Follow-Up in Young Breast Cancer Patients.

Zhao Y, Dong X, Li R, Song J, Zhang D - Transl Oncol (2015)

Patient age with outcome. (A) Patient age in relation to LRFS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 50 months; patients 31 to 35 years old, 87 months. (B) Patient age in relation to DDFS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 65 months; patients 31 to 35 years old, > 99 months. (C) Patient age in relation to OS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 89 months; patients 31 to 35 years old, 92 months.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4562982&req=5

f0010: Patient age with outcome. (A) Patient age in relation to LRFS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 50 months; patients 31 to 35 years old, 87 months. (B) Patient age in relation to DDFS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 65 months; patients 31 to 35 years old, > 99 months. (C) Patient age in relation to OS by Kaplan-Meier survival analysis. Median survival time: patients ≤ 30 years old, 89 months; patients 31 to 35 years old, 92 months.
Mentions: In our study, patient age (≤ 35) was an independent predictor of patient’s prognosis both in univariate and multivariate analyses (Figure 2, A–C, and Tables 1 and 5). Patients younger than 30 have poorer prognosis compared to patients of age between 31 and 35.

Bottom Line: Group 3 in risk factor grouping has the poorer prognosis than the other two groups.Patient age and axillary lymph nodes post-surgery are the independent and significant predictors of distant disease-free survival, local recurrence-free survival, and overall survival.The absence of PR relates to poor prognosis.

View Article: PubMed Central - PubMed

Affiliation: Department of Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, China.

No MeSH data available.


Related in: MedlinePlus